Gritty people have passion and perseverance because their interests absorb them, their work leads them to experience flow, and they believe their work has a purpose.
However, their path to excellence is more than just logging more hours of practice. They log more hours of deliberate practice. They set stretch goals, dedicate themselves to achieving them, ask for critical feedback to improve, and when finished with one goal, they repeat with another stretch goal. Extraordinary achievement is the stringing together of many ordinary achievements of smaller stretch goals along the way.
It is about perseverance over adversity and simply getting up every day for deliberate practice until you finish the season. It is not that gritty people never quit. But, gritty people don't quit on a bad day.
📣 Proud to share HealthBench, an open-source benchmark from our Health AI team at OpenAI, measuring LLM performance and safety across 5000 realistic health conversations. 🧵
Unlike previous narrow benchmarks, HealthBench enables meaningful open-ended evaluation through 48,562 unique physician-written rubric criteria spanning several health contexts (e.g., emergencies, global health) and behavioral dimensions (e.g., accuracy, instruction following, communication).
Blog, paper, code: https://t.co/NsSPeIoHZy
Preprint out today that tests o1-preview's medical reasoning experiments against a baseline of 100s of clinicians.
In this case the title says it all:
Superhuman performance of a large language model on the reasoning tasks of a physician
Link: https://t.co/QB0mawHJNE
A 🧵⬇️
A story of two incredible, incredible humans. Highly encourage you to watch on Amazon Prime video!
@bsw5020 & @sabrevaya thank you for sharing your powerful, heartbreaking, and inspiring story. You’ve shown the world what it means to do something bigger than one’s selves. The ALS community is so lucky to have you
When Brian Wallach was diagnosed with ALS, he was given six months to live. @bsw5020 and @sabrevaya’s film, For Love & Life: No Ordinary Campaign, chronicles their incredible journey, and proves that all of us are far more powerful than we know. I hope you’ll watch it on Prime Video and get involved with their work to find a cure for ALS at https://t.co/qxjrxFwKtq.
When Brian Wallach was diagnosed with ALS, he was given six months to live. @bsw5020 and @sabrevaya’s film, For Love & Life: No Ordinary Campaign, chronicles their incredible journey, and proves that all of us are far more powerful than we know. I hope you’ll watch it on Prime Video and get involved with their work to find a cure for ALS at https://t.co/qxjrxFwKtq.
1/ Large health systems have been held back from expanding into rural markets for years due to non-competes. This will allow large systems to rapidly acquire specialists and their patient referrals. Curious if others have a different opinion🤔
Lots of news in the wake of the FDA non-compete ban, Optum shutting telehealth, and Walmart exiting healthcare...
My take on non-competes:
This is a win for physicians and enables independent practices, but I expect we'll see small health systems and rural players get crunched.
Fourteen years ago today, I signed the Affordable Care Act into law.
Afterwards, one Republican member of the House called the ACA the “most dangerous piece of legislation ever passed in Congress.” Another predicted the country would “never recover from it.”
But then something else happened: it actually worked.
Interested in the buying and selling patterns for digital health in oncology, or how AI is impacting investment in the space?
Check out our latest installment of Flare Capital's Expert Roundtable Series on Oncology below.
https://t.co/QppQnWRbrN
my brother founded a unicorn, ran it well for a long time, is an extremely accomplished investor, is terrible at all video games, and can only squat about 150 pounds.
maybe "unicorn founder jack altman" would be a more reasonable way to introduce him?
Cell therapies are coming under fire this morning. FDA is seeking box label warnings for all 6 approved CAR-T cell therapies. Previous guidance was issued for Legend Biotech and Janssen’s myeloma CAR-T therapies, citing secondary blood cancers following treatment (Dec 21, 2023).
I don’t know if I am more impressed or more upset about the Steelers this year. No offense, but somehow we continue to pull off wins against good teams. No one would consider them a true Super Bowl contender…
Very confusing
I’ve spent a lot of time recently thinking through the shift towards value-based *specialty* care for highly variable patient populations (neuro, onco). The shift will be very slow, but we shouldn’t avoid thinking through ways to engage payers/providers. Breakthroughs are coming
We are thrilled to announce our investment in Visana Health!! We are honored to continue supporting @JConnol and the entire Visana team — as they continue to use technology to build a clinically rigorous women’s health company. @vlan8@uma_veerappan
https://t.co/mO0uvR0Xsj